Healthcare -
Biotechnology - NASDAQ - US
$ 684.01
0.136 %
$ 73.9 B
Market Cap
16.93
P/E
REGN - CAPITAL EXPENDITURES
Capital Expenditures REGN - Regeneron Pharmaceuticals, Inc.
-926 M
LAST VALUE
-29.56%
2 YEAR CAGR
-19.32%
5 YEAR CAGR
-19.48%
10 YEAR CAGR